Friday, 30 June 2023 11:08 amIt's taken almost a year but Aurinia Pharmaceuticals, the US-listed biopharmaceutical company, has finally acquiesced to MKT Capital's demands and formally put itself up for sale.
Thursday, 11 May 2023 8:40 amAnother major shareholder in US-listed biopharmaceutical company Aurinia Pharmaceuticals has publicly come out against the board of the company.
Monday, 24 April 2023 2:38 pmArch rivals at Bloomberg have finally decided to follow up little old Betaville's recent story on the activists trying to shake things up at Aurinia Pharmaceuticals, the US-listed biopharmaceutical company.
Thursday, 23 March 2023 7:18 pmOne of Aurinia Pharmaceutical's largest shareholders has formally submitted an application for a seat on the board of the US-listed company and reiterated its request for the group to consider a formal sale of the business.
Friday, 01 July 2022 3:50 pmAurinia Pharmaceuticals, the US-listed biotechnology company, has come under the spotlight amid a rekindling of takeover speculation and talk the activist investor arguing for a sale of the business may be gearing up to exert more pressure with a fourth letter seeking a board seat.
Thursday, 13 January 2022 7:42 pmIt's been a while since there has been a fresh bid rumour about Aurinia Pharmaceuticals, the US-listed biopharmaceutical company.
Tuesday, 12 October 2021 4:04 pmAurinia Pharmaceuticals, the US-listed biotechnology company developing treatments for rare diseases, is at the centre of a fresh round of takeover speculation.
